Open Access

Kinesin family member 3A inhibits the carcinogenesis of non‑small cell lung cancer and prolongs survival

  • Authors:
    • Yie Yang
    • Xiao Liu
    • Rui Li
    • Mengyu Zhang
    • Hong Wang
    • Yiqing Qu
  • View Affiliations

  • Published online on: October 10, 2020     https://doi.org/10.3892/ol.2020.12211
  • Article Number: 348
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Kinesin family member 3A (KIF3A) plays a crucial role in the carcinogenesis of different types of human cancer. The present study aimed to identify the role of KIF3A in the carcinogenesis of non‑small cell lung cancer (NSCLC). KIF3A protein expression was determined in 163 patients with NSCLC using immunohistochemistry staining. The prognosis of patients with NSCLC was determined using Kaplan‑Meier survival and Cox regression analyses. The function of KIF3A on the carcinogenesis and metastasis of NSCLC was determined in vitro. Furthermore, a protein‑protein interaction (PPI) network of KIF3A was constructed and the potential interacting molecules were identified using bioinformatic analysis. The protein expression levels of KIF3A were significantly lower in the NSCLC tissues compared with that in the adjacent tissues, and low KIF3A expression level was associated with unfavorable survival outcomes in patients with NSCLC. Furthermore, KIF3A knockdown increased proliferation, invasion and metastasis, and inhibited apoptosis of NSCLC cells. KIF3A was demonstrated to interact with intraflagellar transport 57 (IFT57) in the PPI network. In addition, validation analyses indicated that KIF3A mRNA expression levels were positively correlated with IFT57 mRNA expression levels in clinical NSCLC samples and NSCLC cell lines. Taken together, the results of the present study suggested that KIF3A is a key tumor suppressor gene for carcinogenesis and metastasis of NSCLC, it may also function as a biomarker and interacts with IFT57 in the progression of NSCLC.
View Figures
View References

Related Articles

Journal Cover

December-2020
Volume 20 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang Y, Liu X, Li R, Zhang M, Wang H and Qu Y: Kinesin family member 3A inhibits the carcinogenesis of non‑small cell lung cancer and prolongs survival. Oncol Lett 20: 348, 2020.
APA
Yang, Y., Liu, X., Li, R., Zhang, M., Wang, H., & Qu, Y. (2020). Kinesin family member 3A inhibits the carcinogenesis of non‑small cell lung cancer and prolongs survival. Oncology Letters, 20, 348. https://doi.org/10.3892/ol.2020.12211
MLA
Yang, Y., Liu, X., Li, R., Zhang, M., Wang, H., Qu, Y."Kinesin family member 3A inhibits the carcinogenesis of non‑small cell lung cancer and prolongs survival". Oncology Letters 20.6 (2020): 348.
Chicago
Yang, Y., Liu, X., Li, R., Zhang, M., Wang, H., Qu, Y."Kinesin family member 3A inhibits the carcinogenesis of non‑small cell lung cancer and prolongs survival". Oncology Letters 20, no. 6 (2020): 348. https://doi.org/10.3892/ol.2020.12211